1995
DOI: 10.1016/s0140-6736(95)90471-9
|View full text |Cite
|
Sign up to set email alerts
|

A new method for active surveillance of adverse events from diphtheria/tetanus/pertussis and measles/mumps/rubella vaccines

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

5
122
2
5

Year Published

1997
1997
2012
2012

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 294 publications
(134 citation statements)
references
References 11 publications
5
122
2
5
Order By: Relevance
“…In 1992 the distribution of Pluserix™ was voluntarily suspended in countries where an alternative was available, following concerns over the number of cases (estimated at 1 per 2,600 vaccinees) of aseptic meningitis associated with the Urabe Am 9 mumps strain [2,3]. A third MMR vaccine, Triviraten™ (Swiss Berna), with the Rubini mumps strain elicits good antibody responses but has poor efficacy against mumps resulting in epidemics in Switzerland [4,5], Italy [6] and Portugal [7].…”
Section: Introductionmentioning
confidence: 99%
“…In 1992 the distribution of Pluserix™ was voluntarily suspended in countries where an alternative was available, following concerns over the number of cases (estimated at 1 per 2,600 vaccinees) of aseptic meningitis associated with the Urabe Am 9 mumps strain [2,3]. A third MMR vaccine, Triviraten™ (Swiss Berna), with the Rubini mumps strain elicits good antibody responses but has poor efficacy against mumps resulting in epidemics in Switzerland [4,5], Italy [6] and Portugal [7].…”
Section: Introductionmentioning
confidence: 99%
“…In reviewing these cases the two clinical experts applied the tighter time frame of 15-35 days post vaccination to indicate causality rather than the 6-week period on the monthly report cards. It is well documented that the characteristic post-vaccination period for mumps vaccine complications is 15-35 days, while complications due to the measles component usually occur during 6-11 days post vaccination [4,9,13].The criteria used to define a case of associated MMR vaccine viral aseptic meningitis are shown in table 1.…”
Section: Case Definitionmentioning
confidence: 99%
“…In a record linkage study in the UK [9], the risk of aseptic meningitis following vaccination with the Urabe strain of mumps was found to be higher compared to the risk following vaccination with the other widely used mumps strain Jeryl-Lynn.This led in 1992 to the discontinuation of use of vaccines containing the Urabe mumps strain in some countries, including Germany [10], where vaccination continued with two MMR vaccines containing the Jeryl-Lynn mumps strain.…”
Section: Introductionmentioning
confidence: 95%
“…Das ist ein Schwachpunkt und eine Grenze des Systems und erfordert Überlegungen zur Etablierung neuer aktiver Überwachungssysteme (z. B. Verknüpfung von großen Datenbanken [25]). …”
Section: Melderate Von Verdachtsfällen Von Nebenwirkungen (Uaw) Von 1unclassified